findmyKOL

John Funai, MD

Basic profile

Cardiovascular Disease

ORCIDNone on fileNPI
RegionLihue, HI · WestSpecialtyCardiovascular DiseaseFocusCardiology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2017Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

John Funai is a Cardiology physician. OpenAlex indexes 7 publications with 239 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
7publications

Distinct works indexed by OpenAlex.

239citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

3-3420 Kuhio Hwy
Suite B
Lihue, HI 967661098

Telephone

808-245-1548

Registry record last updated 16 Sept 2010.

View the NPPES registry record

Industry payments

2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    60.6%
    Angiotensin receptor-neprilysin inhibitor (ARNI)13.3%
    Entresto100%
    Part D257 patients
    Beta blocker12.7%
    Metoprolol Succinate59%Carvedilol22%Metoprolol Tartrate11%Atenolol7%Sotalol1%
    Part D<11 patients

    + 17 more classes in this area

  • Metabolism & gastrointestinal

    20.1%
    SGLT2 inhibitor16.8%
    Jardiance96%Farxiga4%
    Part D<11 patients
    GLP-1 receptor agonist2.3%
    Wegovy57%Ozempic44%
    Part D29 patients

    + 2 more classes in this area

  • Blood & clotting

    18.4%
    Factor Xa inhibitor15.2%
    Xarelto54%Eliquis46%
    Part D127 patients
    P2Y12 inhibitor3.1%
    Clopidogrel92%Brilinta8%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)31.5% facility · 68.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”